A bite-sized review of life science current events you need to know about this week.
A $50,000 grant will let four medical schools, including Albert Einstein College of Medicine at Yeshiva University, study how aspiring physicians use social media and what ethical issues it creates with patients. As part of the grant, medical students and faculty will learn how to use social media “appropriately and effectively.”
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
An Indianapolis hospital used video conferencing to reduce its readmission rate for heart patients to 3 percent. Patients met with a nurse via a video conferencing device up to six times in the 30 days after they left the hospital.
A new med tech accelerator is launching in Minnesota with a focus on class 2 medical devices, especially in orthopedics and urology.
San Francisco startup Dabo Health is partnering with Mayo Clinic to pilot its data tool aimed a driving down readmission rates and mortality rates in three health conditions: heart attack, heart failure and pneumonia.
Longitude Venture Partners, a VC firm that invests in medical device, biotechnology, diagnostics and R&D tools, has raised more than $331 million for a second fund and could continue raising up to $375 million.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
We didn’t write these, but you should read them anyway.
Who can buy drugs during a sour economy? Apparently, people who cut other expenses. (Pharmalot)
Doctors in England are saying that UK hospitals are on the verge of collapse. (BBC News)
An inexperienced team, bad marketing and eight other reasons why first-time entrepreneurs fail. (Young Entrepreneur)
How are pharmas surviving Pharmageddon? Not by buying advertising. (AdAge)
Assembling the mHealth evidence puzzle. (iMedicalApps)
Tweets we liked this week.
What to do when your hospital gets “worse than” ratings: Stop Ignoring Low Quality Ratings buff.ly/Q2pgij #hcsm
— Hive Strategies (@HiveDan) September 13, 2012
First 6 #greatchallenges in health and medicine up for discussion. Talk w/experts and share your ideas! @tedmedchallenges.tedmed.com
— TEDMED (@TEDMED) September 12, 2012
Practice Management column: 6 marketing tips that don’t include social media bit.ly/S3kkcc
— AmericanMedicalNews (@amednews) September 13, 2012
570,000 US dialysis patients account for 7% of medicare costs and more than 10% of medicare expenses #txfm Amy Williams
— Arundhati Parmar (@aparmarbb) September 11, 2012
